Finoriq research workspace
Alkermes plc. (ALKS) Institutional Holdings & 13F Ownership
Alkermes plc, a biopharmaceutical company, engages in the research, development. Review ALKS institutional holders, 13F ownership, and position changes on Finoriq.
Company Snapshot
Alkermes plc, a biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally. The company has a portfolio of proprietary commercial products for the treatment of opioid dependence, alcohol dependence, schizophrenia, bipolar I, and a pipeline of clinical and preclinical product candidates in development for neurological disorders. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ARISTADA INITIO for the treatment of schizophrenia in adults; VIVITROL for the treatment of alcohol and prevention of opioid dependence; LYBALVI, an oral atypical antipsychotic drug candidate for the treatment of adults with schizophrenia and bipolar I disorder; and LUMRYZ, an extended-release oral suspension product for the treatment of cataplexy or EDS in pediatric patients. The company also offers proprietary technology platforms to third parties to enable them to develop, commercialize, and manufacture products. It has collaboration agreements primarily with Janssen Pharmaceutica N.V., Janssen Pharmaceutica Inc, and Janssen Pharmaceutica International. Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland.
- Company
- Alkermes plc. (ALKS)
- Ticker
- ALKS
- Market Cap
- $8.7B
- Latest Price
- $52.25
- Industry
- Biotech & Pharma
Alkermes plc. (ALKS) Top Institutional Holders
Top current 13F holders indexed for Alkermes plc. (ALKS). Latest period 2026-03-31.
| Rank | Investor | Value | Portfolio | Filing |
|---|---|---|---|---|
| 1 | Ken FisherCIK 0000850529 | $13.8M | 0.0% | Filing2026-05-05 |
| 2 | Ray DalioCIK 0001350694 | $3M | 0.01% | Filing2026-05-15 |
| 3 | Joel GreenblattCIK 0001510387 | $1.5M | 0.0% | Filing2026-05-15 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.